Background

The blood–brain barrier (BBB) tightly regulates what gets in and out of the brain from the bloodstream. Adenosine is a signalling molecule produced by different cell types in our body that is known to loosen the BBB in conditions like sleep deprivation. What remained unknown was if adenosine acts differently depending on which side of the barrier it hits.

Research

Using BBB cell cultures and animal models, the team applied adenosine to either the blood-facing or brain-facing side of the barrier. The effects were opposite: adenosine tightened the barrier from the blood side but opened it from the brain side, with the opening driven specifically by so-called A2A receptors.

Potential Impact

This recasts adenosine as a directional signal, not a simple barrier-opener, which matters for diseases like stroke and chronic sleep loss where adenosine builds up in the brain. It also points to A2A receptor antagonists as a way to protect the barrier, or conversely, to open it on purpose for drug delivery.